Table 3.
Binding of 4-hydroxy-1,2,3-triazole Glu analogues to AMPA receptor subtypes.
| Ligand | GluA1o | GluA2(R)o | GluA3o | GluA4o | GluA2o-ABD | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ki (μM) | nH | Ki (μM) | nH | Ki (μM) | nH | Ki (μM) | nH | Ki (μM) | nH | |
| (S)-2 | 0.022 | n.d. | 0.017 | n.d. | 0.021 | n.d. | 0.040 | n.d. | n.d. | n.d. |
| 5a | 0.0052 | n.d. | 0.0039 | n.d. | 0.0022 | n.d. | 0.0027 | n.d. | n.d. | n.d. |
| 5b | 7.7 | n.d. | 0.75 | n.d. | 0.39 | n.d. | 0.20 | n.d. | n.d. | n.d. |
| 6a | 15.7 ± 1.1# | 1.02 ± 0.17 | 1.87 ± 0.72# | 0.95 ± 0.09 | 4.98 ± 0.58 | 0.95 ± 0.25 | 4.08 ± 1.66 | 0.89 ± 0.07 | n.d. | n.d. |
| 6b | 9.02 ± 2.27## | 0.62 ± 0.04 | 0.71 ± 0.22**,## | 0.99 ± 0.04 | 1.91 ± 0.44 | 0.99 ± 0.03 | 9.47 ± 1.95 | 0.72 ± 0.03 | 0.32 ± 0.03** | 1.01 ± 0.15 |
| 6c | 54.1 ± 8.6### | 0.81 ± 0.07 | 3.25 ± 0.47### | 1.55 ± 0.65 | 11.9 ± 2.9 | 0.75 ± 0.09 | ≈ 100 | n.d. | n.d. | n.d. |
| 7a | 73 ± 34 | 0.97 ± 0.17 | 4.38 ± 2.18* | 0.80 ± 0.06 | 4.89 ± 0.51 | 0.82 ± 0.05 | 11.6 ± 2.1 | 0.91 ± 0.24 | 1.97 ± 0.17* | 0.92 ± 0.05 |
| 7b | > 100 | n.d. | > 100 | n.d. | ≈ 100 | n.d. | > 100 | n.d. | n.d. | n.d. |
| 7c | > 100 | n.d. | > 100 | n.d. | > 100 | n.d. | > 100 | n.d. | n.d. | n.d. |
Shown are means ± SEM from n ≥ 3 experiments conducted in triplicate at 12-15 ligand concentrations. n.d., not determined.
GluA2 not statistically significantly different from GluA2-ABD (p > 0.05, t-test).
GluA2 not statistically significantly different from GuA2-ABD (p > 0.05, t-test).
Ki at GluA1 statistically significantly different from GluA2 (p < 0.05, t-test).